Cargando…

The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo

BACKGROUND: Long non-coding RNAs (lncRNAs) can orchestrate oncogenic or tumor-suppressive functions in cancer biology. Accordingly, PCGEM1 and PRNCR1 were implicated in progression of prostate cancer (PCa) as transcriptional co-regulators of the androgen receptor (AR). However, these findings were r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parolia, Abhijit, Crea, Francesco, Xue, Hui, Wang, Yuwei, Mo, Fan, Ramnarine, Varune Rohan, Liu, Hui Hsuan, Lin, Dong, Saidy, Nur Ridzwan Nur, Clermont, Pier-Luc, Cheng, Hongwei, Collins, Colin, Wang, Yuzhuo, Helgason, Cheryl D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342943/ https://www.ncbi.nlm.nih.gov/pubmed/25744782 http://dx.doi.org/10.1186/s12943-015-0314-4

Ejemplares similares

The non-coding transcriptome as a dynamic regulator of cancer metastasis
por: Crea, Francesco, et al.
Publicado: (2013)

miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer
por: Nabavi, Noushin, et al.
Publicado: (2017)

Polycomb-mediated silencing in neuroendocrine prostate cancer
por: Clermont, Pier-Luc, et al.
Publicado: (2015)

Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
por: Clermont, Pier-Luc, et al.
Publicado: (2016)

Regulation of androgen receptor splice variant AR3 by PCGEM1
por: Zhang, Ziqiang, et al.
Publicado: (2016)

The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program
por: Parolia, Abhijit, et al.
Publicado: (2019)

Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer
por: Crea, Francesco, et al.
Publicado: (2014)

Integrated analysis of the prostate cancer small‐nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression
por: Crea, Francesco, et al.
Publicado: (2015)

Regulation of PCGEM1 by p54/nrb in prostate cancer
por: Ho, Tsui-Ting, et al.
Publicado: (2016)

Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer
por: Feng, Ye, et al.
Publicado: (2019)

The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer
por: Prensner, John R., et al.
Publicado: (2014)

LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility
por: Su, Yuanshuai, et al.
Publicado: (2022)

Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role
por: Clermont, P-L, et al.
Publicado: (2014)

Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2013)

Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells
por: He, Jin-Hua, et al.
Publicado: (2014)

PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1
por: Liu, He, et al.
Publicado: (2022)

LncRNA PCGEM1 contributes to malignant behaviors of glioma by regulating miR-539-5p/CDK6 axis
por: Liu, Shu-Li, et al.
Publicado: (2021)

lncRNA PCGEM1 Regulates the Progress of Colorectal Cancer through Targeting miR-129-5p/SOX4
por: Guan, Bingsheng, et al.
Publicado: (2022)

Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer
por: Qu, Sifeng, et al.
Publicado: (2018)

lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma
por: Xu, Zhenxing, et al.
Publicado: (2020)

Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer
por: Lee, Ahn R., et al.
Publicado: (2018)

PCGEM1 promotes cell proliferation and migration in endometriosis by targeting miR-124-3p-mediated ANTXR2 expression
por: Liu, Yong, et al.
Publicado: (2023)

Development of a Transcriptional Amplification System Based on the PEG3 Promoter to Target Androgen Receptor-Positive and -Negative Prostate Cancer Cells
por: Jain, Pallavi, et al.
Publicado: (2019)

Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR‐433‐3p and Targeting OMA1
por: Li, Jun, et al.
Publicado: (2023)

LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP
por: Weng, Lei, et al.
Publicado: (2020)

The long noncoding RNA PCGEM1 promotes cell proliferation, migration and invasion via targeting the miR-182/FBXW11 axis in cervical cancer
por: Zhang, Qian, et al.
Publicado: (2019)

Next generation patient-derived prostate cancer xenograft models
por: Lin, Dong, et al.
Publicado: (2014)

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
por: Ramnarine, Varune Rohan, et al.
Publicado: (2018)

MEF2-activated long non-coding RNA PCGEM1 promotes cell proliferation in hormone-refractory prostate cancer through downregulation of miR-148a
por: Zhang, Shibao, et al.
Publicado: (2018)

MechRNA: prediction of lncRNA mechanisms from RNA–RNA and RNA–protein interactions
por: Gawronski, Alexander R, et al.
Publicado: (2018)

Long non-coding RNA-PCGEM1 contributes to prostate cancer progression by sponging microRNA miR-129-5p to enhance chromatin licensing and DNA replication factor 1 expression
por: Fu, Qiao, et al.
Publicado: (2022)

LncRNA PCGEM1 induces proliferation and migration in non-small cell lung cancer cells through modulating the miR-590-3p/SOX11 axis
por: Wen, Huanshun, et al.
Publicado: (2021)

Association between prenatal androgens and cord blood androgens, a path analysis
por: Xu, Hui, et al.
Publicado: (2023)

Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation
por: Fornaro, Lorenzo, et al.
Publicado: (2017)

Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient‐derived, advanced prostate cancer tissue xenograft model
por: Qu, Sifeng, et al.
Publicado: (2013)

Smile Attractiveness and Treatment Needs of Maxillary Midline Diastema with Various Widths: Perception among Laypersons, Dental Students, and Dentists in Malaysia
por: Sabri, Nur Amirah Binti Mohamad, et al.
Publicado: (2023)

Retraction Note: LncRNA PCGEM1 induces proliferation and migration in non-small cell lung cancer cells through modulating the miR-590-3p/SOX11 axis
por: Wen, Huanshun, et al.
Publicado: (2022)

The emerging role of histone lysine demethylases in prostate cancer
por: Crea, Francesco, et al.
Publicado: (2012)

Modeling Androgen Deprivation Therapy–Induced Prostate Cancer Dormancy and Its Clinical Implications
por: Dong, Xin, et al.
Publicado: (2022)

Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
por: Lin, Dong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5eehb1tbmpvkispdq081lv6lmn